The list of proposed INN names and their cas numbers and the originator company. The list will be updated as and when we come to know the companies for other molecules. Keep visiting.
For labcodes, clinical trials, developer, indication and other details please use the website Drug spider
English Name
|
CAS Number
|
Originator Company
|
adegramotide
|
1252802-98-4
|
|
adomeglivant
|
1488363-78-5
|
Eli Lilly
|
afabicin
|
1518800-35-5
|
Affinium Pharmaceuticals
|
agerafenib
|
1188910-76-0
|
Ambit Biosciences Corporation
|
alicapistat
|
1254698-46-8
|
Abbott Laboratories
|
alidornase alfa
|
1788036-49-6
|
|
andecaliximab
|
1518996-49-0
|
Gilead Sciences
|
apararenone
|
945966-46-1
|
Mitsubishi Tanabe Pharma Corporation
|
apimostinel
|
1421866-48-9
|
Naurex
|
aprutumab
|
1634620-63-5
|
Bayer
|
aprutumab ixadotin
|
1708947-48-1
|
|
asciminib
|
1492952-76-7
|
Novartis
|
atuveciclib
|
1414943-94-4
|
Bayer
|
audencel
|
||
birabresib
|
202590-98-5
|
Mitsubishi Pharma Corporation
|
branaplam
|
1562338-42-4
|
Novartis
|
brazikumab
|
1610353-18-8
|
|
brilanestrant
|
1365888-06-7
|
Aragon Pharmaceuticals
|
burosumab
|
1610833-03-8
|
Kyowa Hakko Kirin
|
camrelizumab
|
1798286-48-2
|
|
cannabidiol
|
13956-29-1
|
GW Pharma
|
casimersen
|
1422958-19-7
|
|
cenegermin
|
1772578-74-1
|
|
cenplacel
|
||
crizanlizumab
|
1690318-25-2
|
|
cupabimod
|
297774-48-2
|
|
darolutamide
|
1297538-32-9
|
Orion
|
depatuxizumab
|
1471999-69-5
|
Abbott Laboratories
|
depatuxizumab mafodotin
|
1585973-65-4
|
Abbott Laboratories
|
dexisometheptene
|
1620401-56-0
|
Tonix Pharmaceuticals
|
dezamizumab
|
1662664-56-3
|
Pentraxin Therapeutics
|
diroximel fumarate
|
1577222-14-0
|
Alkermes plc
|
elacestrant
|
722533-56-4
|
Eisai Co Ltd
|
elapegademase
|
1709806-75-6
|
|
elezanumab
|
1791416-49-3
|
Abbott Laboratories
|
elivaldogene tavalentivec
|
1905397-73-0
|
|
eltrapuldencel
|
||
emapalumab
|
1709815-23-5
|
|
ensartinib
|
1370651-20-9
|
Xcovery
|
enzaplatovir
|
1323077-89-9
|
Biota Holdings
|
epertinib
|
908305-13-5
|
Shionogi
|
eptinezumab
|
1644539-04-7
|
Alder Biopharmaceuticals
|
erenumab
|
1582205-90-0
|
Amgen
|
eretidigene velentivec
|
1800541-90-5
|
|
evobrutinib
|
1415823-73-2
|
Merck Serono
|
fezolinetant
|
1629229-37-3
|
Euroscreen
|
flurdihydroergotamine
|
1416417-27-0
|
MAP pharma
|
follitropin epsilon
|
1359819-75-2
|
|
fostemsavir
|
864953-29-7
|
Bristol-Myers Squibb
|
fremanezumab
|
1655501-53-3
|
Rinat Neuroscience
|
gemtuzumab ozogamicin
|
220578-59-6
|
UCB
|
golodirsen
|
1422959-91-8
|
|
hemoglobin betafumaril (bovine)
|
1797415-38-3
|
|
ilmetropium iodide
|
129109-88-2
|
|
imlatoclax
|
1257050-45-5
|
Abbvie
|
inotersen
|
1492984-65-2
|
Isis Pharmaceuticals
|
itacitinib
|
1334298-90-6
|
Incyte Corporation
|
larotrectinib
|
1223403-58-4
|
Array BioPharma
|
lisavanbulin
|
1263384-43-5
|
Basilea Pharmaceutica
|
lumicitabine
|
1445385-02-3
|
Alios BioPharma
|
lupartumab
|
1640971-88-5
|
Bayer
|
lupartumab amadotin
|
1640972-00-4
|
|
lutikizumab
|
1791411-57-8
|
Abbott Laboratories
|
miridesap
|
224624-80-0
|
Pentraxin Therapeutics
|
mivebresib
|
1445993-26-9
|
AbbVie
|
nacubactam
|
1452458-86-4
|
Fedora Pharmaceuticals
|
naquotinib
|
1448232-80-1
|
Astellas Pharma
|
navoximod
|
1402837-78-8
|
Newlink genetics
|
nelatimotide
|
1629213-88-2
|
|
nirogacestat
|
1290543-63-3
|
Pfizer
|
obicetrapib
|
866399-87-3
|
Mitsubishi Tanabe Pharma Corporation
|
ofranergene obadenovec
|
1476737-24-2
|
|
padsevonil
|
1294000-61-5
|
UCB
|
palucorcel
|
||
pegunigalsidase alfa
|
1644392-61-9
|
|
pegvorhyaluronidase alfa
|
1620390-06-8
|
|
pimodivir
|
1629869-44-8
|
Vertex Pharmaceuticals
|
poseltinib
|
1353562-97-2
|
|
ranevetmab
|
1632282-27-9
|
|
ravoxertinib
|
1453848-26-4
|
Array BioPharma
|
recanaclotide
|
1667762-62-0
|
|
reltecimod
|
1447799-33-8
|
|
remetinostat
|
946150-57-8
|
Dana-Farber Cancer Institute, Harvard
University
|
remtolumab
|
1791410-27-9
|
Abbott Laboratories
|
rogaratinib
|
1443530-05-9
|
|
rosiptor
|
782487-28-9
|
|
rosmantuzumab
|
1684393-04-1
|
|
rosomidnar
|
871597-03-4
|
ProNAi Therapeutics
|
rozanolixizumab
|
1584645-37-3
|
UCB
|
sacituzumab
|
1796566-95-4
|
|
satoreotide
|
1801415-23-5
|
|
seladelpar
|
851528-79-5
|
Ortho-McNeil
|
seltorexant
|
1293281-49-8
|
|
serabelisib
|
1268454-23-4
|
Intellikine
|
sofpironium bromide
|
1628106-94-4
|
Bodor Laboratory
|
somatrogon
|
1663481-09-1
|
|
suptavumab
|
1629615-23-1
|
Regeneron Pharmaceuticals
|
tavolixizumab
|
1635395-25-3
|
|
telisotuzumab
|
1781223-80-0
|
Pierre Fabre
|
telisotuzumab vedotin
|
1714088-51-3
|
AbbVie
|
tenofovir exalidex
|
911208-73-6
|
|
tirabrutinib
|
1351636-18-4
|
Ono Pharmaceutical
|
tonabacase
|
1788041-31-5
|
|
tonogenconcel
|
||
tozuleristide
|
1673565-40-6
|
|
trastuzumab duocarmazine
|
1642152-40-6
|
|
tucidinostat
|
1616493-44-7
|
|
upadacitinib
|
1310726-60-3
|
Abbott Laboratories
|
uprifosbuvir
|
1496551-77-9
|
|
utomilumab
|
1417318-27-4
|
Pfizer
|
valnivudine
|
956483-02-6
|
|
vamorolone
|
13209-41-1
|
ReveraGen BioPharma
|
vandefitemcel
|
||
velagliflozin
|
946525-65-1
|
|
vestronidase alfa
|
1638194-78-1
|
|
voretigene neparvovec
|
1646819-03-5
|
The Childrens Hospital of Philadelphia
|
vorolanib
|
1013920-15-4
|
|
vunakizumab
|
1792181-33-9
|
